Ulipristal acetate for uterine fibroids: a systematic review and meta-analysis.

Author: BoutasIoannis, KalampokasEmmanouil, KalampokasTheodoros, KamathMohan

Paper Details 
Original Abstract of the Article :
Ulipristal acetate (UA), a selective progesterone modulator, has been approved for short-term therapy for symptomatic fibroids. We decided to undertake a systematic review of the best available evidence and draw a more definitive conclusion regarding the efficacy of UA for the management of uterine ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.3109/09513590.2015.1106471

データ提供:米国国立医学図書館(NLM)

Ulipristal Acetate: A Oasis of Relief for Uterine Fibroids

Uterine fibroids, those pesky growths in the uterus, can be a source of discomfort and disruption. This review explores the effectiveness of ulipristal acetate (UA), a selective progesterone modulator, in managing uterine fibroids. The review examines the available evidence on UA's ability to provide symptomatic relief, reduce fibroid size, and minimize side effects.

A Promising Treatment for Uterine Fibroids

The review found that UA was effective in providing symptomatic relief, particularly for excessive uterine bleeding. It also resulted in a reduction in fibroid size and improved quality of life. While there were some non-physiological endometrial changes associated with UA, these were typically reversible.

Finding a Path to Relief from Fibroids

This review highlights the potential benefits of UA for treating uterine fibroids. It's like finding a refreshing oasis in the desert of fibroid-related symptoms, offering relief and a path to improved well-being.

Dr. Camel's Conclusion

This review explores the effectiveness of ulipristal acetate (UA) for managing uterine fibroids. The findings suggest that UA can be a valuable option for providing symptomatic relief, reducing fibroid size, and improving quality of life. It's a reminder that the desert of gynecological health is full of challenges, but new and innovative treatments are constantly emerging to provide support and relief for patients.

Date :
  1. Date Completed 2016-12-13
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26572056

DOI: Digital Object Identifier

10.3109/09513590.2015.1106471

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.